Citi Starts Onconova Therapeutics (ONTX) at Neutral
- Nasdaq outshines Wall St peers on tech boost, earnings glee
- Tesla touts acceleration of new models, but Q1 results fall short of estimates
- Boeing reports first revenue drop in 7 quarters as deliveries decline
- Oil prices steady after rallying on US stock decline, business data
- Yen on the brink, but Tesla pulls back
- Fisker (FSR) Appoints Michael Healy as Chief Restructuring Officer
- Seagate Technology (STX) Enters $600M Asset Purchase Agreement with Avago
- China acquired top-end Nvidia AI chips despite recent US ban- Reuters
- Hasbro (HAS) brand strength sees earnings top expectations
- Wolfe Research Downgrades Warner Brothers Discovery (WBD) to Underperform, 'out of concern that an incipient advertising downturn put guidance at risk'
- Tesla, AT&T, Biogen and Hasbro rise premarket; Uber, Enphase fall
- After-hours movers: Tesla, Texas Instruments, Seagate, Visa and more
- Midday movers: PepsiCo, JetBlue fall; GM, Danaher and UPS rise
- After-hours movers: Cadence Design Systems, Cleveland-Cliffs, Riot Platforms, and more
- Midday movers: Tesla, Li Auto and CNH Industrial fall; Salesforce rises
Leerink Swann Starts Onconova Therapeutics (ONTX) at Outperform
August 19, 2013 11:31 AM EDTLeerink Swann initiated coverage on Onconova Therapeutics (NASDAQ: ONTX) with an Outperform rating and a price target of $25.00. Analyst analyst Howard Liang believes risk/reward is attractive.
"Although the Phase III ONTIME readout is clearly a binary event and there is considerable... More
Janney Starts Onconova Therapeutics (ONTX) at Buy
August 19, 2013 6:53 AM EDTJanney Montgomery Scott initiates coverage on Onconova Therapeutics (NASDAQ: ONTX) with a Buy. PT $40.00.
For an analyst ratings summary and ratings history on Onconova Therapeutics click here. For more ratings news on Onconova Therapeutics click here.
Shares of Onconova Therapeutics closed at $25.69 yesterday, with a 52 week range of $19.42-$30.00.... More
Piper Jaffray Starts Onconova Therapeutics (ONTX) at Overweight
August 19, 2013 6:51 AM EDTPiper Jaffray initiates coverage on Onconova Therapeutics (NASDAQ: ONTX) with a Overweight. PT $38.00.
For an analyst ratings summary and ratings history on Onconova Therapeutics click here. For more ratings news on Onconova Therapeutics click here.
Shares of Onconova Therapeutics closed at $25.69 yesterday, with a 52 week range of $19.42-$30.00.... More